Erasca Foundation proposes sale of 8,333 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Erasca, Inc. (ERAS) is the issuer named in Erasca Foundation’s notice of a proposed sale of 8,333 common shares, with an approximate market value of $129,255.86 and approximate sale date of November 16, 2026. The foundation acquired 1,093,557 shares by donation from Erasca, Inc. on July 20, 2021. The notice lists May 21, 2026 as the plan-adoption or instruction date if relying on Rule 10b5-1.
Key Figures
Key Terms
Rule 10b5-1 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.